Late Infections Seen With Rituxan in Vasculitis MedPage Today LIVERPOOL -- Treatment of vasculitis associated with antineutrophil cytoplasmic antibodies (ANCA) with rituximab (Rituxan) is known to be effective, but in a U.K. cohort was associated with an increase in late-onset infections, a researcher reported here. |
